Brian J. Lynch
Net Worth

Last updated:

What is Brian J. Lynch net worth?

The estimated net worth of Mr. Brian J. Lynch is at least $15,498,516 as of 5 Dec 2023. He owns shares worth $5,775,385 as insider, has earned $7,628,981 from insider trading and has received compensation worth at least $2,094,150 in Madrigal Pharmaceuticals, Inc..

What is the salary of Brian J. Lynch?

Mr. Brian J. Lynch salary is $698,050 per year as Senior Vice President & Gen. Counsel in Madrigal Pharmaceuticals, Inc..

How old is Brian J. Lynch?

Mr. Brian J. Lynch is 63 years old, born in 1962.

What stocks does Brian J. Lynch currently own?

As insider, Mr. Brian J. Lynch owns shares in one company:

Company Title Shares Price per share Total value
Madrigal Pharmaceuticals, Inc. (MDGL) Senior Vice President & Gen. Counsel 15,001 $385 $5,775,385

What does Madrigal Pharmaceuticals, Inc. do?

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

MDGL logo
MDGL
Madrigal Pharmaceuticals, Inc.
$385

Brian J. Lynch insider trading

Madrigal Pharmaceuticals, Inc.

Mr. Brian J. Lynch has made 32 insider trades between 2022-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 13,000 units of MDGL stock on 3 Jan 2023. As of 5 Dec 2023 he still owns at least 15,001 units of MDGL stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 1,000 $87.09 $87,090
Option
Stock Option (Right to Buy) 1,000 $87.09 $87,090
Sale
Common Stock 1,000 $227.33 $227,330
Option
Common Stock 1,000 $87.09 $87,090
Sale
Common Stock 1,000 $221.38 $221,380
Sale
Common Stock 800 $215.73 $172,584
Option
Common Stock 800 $73.75 $59,000
Option
Stock Option (Right to Buy) 800 $73.75 $59,000
Option
Stock Option (Right to Buy) 1,000 $87.09 $87,090
Sale
Common Stock 1,000 $206.73 $206,730
Sale
Common Stock 1,000 $203 $203,000
Option
Stock Option (Right to Buy) 3,000 $73.75 $221,250
Option
Common Stock 3,000 $73.75 $221,250
Sale
Common Stock 1,000 $204 $204,000
Option
Stock Option (Right to Buy) 4,000 $73.75 $295,000
Option
Common Stock 4,000 $73.75 $295,000
Sale
Common Stock 3,000 $199.45 $598,350
Sale
Common Stock 1,000 $198.4 $198,400
Sale
Common Stock 2,656 $281.97 $748,912
Sale
Common Stock 1,800 $280.66 $505,188
Sale
Common Stock 400 $279.1 $111,640
Sale
Common Stock 600 $277.91 $166,746
Option
Stock Option (Right to Buy) 13,000 $91.79 $1,193,270
Sale
Common Stock 100 $287.86 $28,786
Sale
Common Stock 2,628 $282.97 $743,645
Sale
Common Stock 829 $285.15 $236,389
Sale
Common Stock 1,549 $283.85 $439,684
Option
Common Stock 13,000 $91.79 $1,193,270
Sale
Common Stock 400 $286.62 $114,648
Sale
Common Stock 2,038 $285.74 $582,338
Sale
Common Stock 200 $283.61 $56,722
Option
Stock Option (Right to Buy) 7,000 $91.79 $642,530
Option
Common Stock 7,000 $91.79 $642,530
Sale
Common Stock 200 $280.41 $56,082
Sale
Common Stock 200 $281.79 $56,358
Sale
Common Stock 1,100 $279.46 $307,406
Sale
Common Stock 361 $277.77 $100,275
Sale
Common Stock 100 $276.4 $27,640
Sale
Common Stock 100 $275.24 $27,524
Sale
Common Stock 400 $274.7 $109,880
Sale
Common Stock 539 $273.48 $147,406
Sale
Common Stock 1,500 $272.74 $409,110
Sale
Common Stock 800 $271.27 $217,016
Sale
Common Stock 700 $270.25 $189,175
Sale
Common Stock 300 $268.99 $80,697
Sale
Common Stock 500 $267.88 $133,940

Madrigal Pharmaceuticals key executives

Madrigal Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: